Mary Custer

2.5k total citations · 1 hit paper
26 papers, 2.1k citations indexed

About

Mary Custer is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mary Custer has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 12 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Mary Custer's work include Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (8 papers) and CAR-T cell therapy research (7 papers). Mary Custer is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (8 papers) and CAR-T cell therapy research (7 papers). Mary Custer collaborates with scholars based in United States, Netherlands and Italy. Mary Custer's co-authors include Steven A. Rosenberg, Michael T. Lotze, Michael I. Nishimura, Timothy M. Clay, Anthony A. Rayner, Claudia A. Seipp, Yvedt L. Matory, Stephen E. Ettinghausen, S O Sharrow and Jessica Sachs and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Mary Custer

26 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1985 488 citations Michael T. Lotze, Mary Custer et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Custer United States	18	1.3k	919	681	405	136	26	2.1k
Naoko Nakano Japan	13	1.3k 0.9×	525 0.6×	408 0.6×	188 0.5×	121 0.9×	26	1.9k
Yonglian Sun United States	27	1.5k 1.1×	516 0.6×	346 0.5×	280 0.7×	86 0.6×	39	2.1k
Jonathan H. Esensten United States	16	1.4k 1.1×	678 0.7×	437 0.6×	326 0.8×	81 0.6×	21	2.3k
Atsuo Nakajima Japan	19	1.1k 0.8×	445 0.5×	383 0.6×	219 0.5×	178 1.3×	34	1.8k
Claire N. Manzotti United Kingdom	11	1.9k 1.4×	869 0.9×	251 0.4×	215 0.5×	55 0.4×	12	2.3k
David M. Kofler Germany	20	703 0.5×	475 0.5×	572 0.8×	461 1.1×	64 0.5×	43	1.6k
Dass S. Vinay United States	24	1.7k 1.3×	797 0.9×	302 0.4×	126 0.3×	96 0.7×	44	2.3k
Benjamin Joachim Schmiedel Germany	21	995 0.7×	488 0.5×	603 0.9×	184 0.5×	69 0.5×	44	1.7k
Geoff Nichol United States	7	984 0.7×	1.4k 1.5×	1.0k 1.5×	402 1.0×	87 0.6×	9	2.5k
Theodora W. Salcedo United States	18	931 0.7×	495 0.5×	403 0.6×	104 0.3×	237 1.7×	30	1.5k

Countries citing papers authored by Mary Custer

Since Specialization

Citations

This map shows the geographic impact of Mary Custer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Custer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Custer more than expected).

Fields of papers citing papers by Mary Custer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Custer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Custer. The network helps show where Mary Custer may publish in the future.

Co-authorship network of co-authors of Mary Custer

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Custer. A scholar is included among the top collaborators of Mary Custer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Custer. Mary Custer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Risinger, John I., Mary Custer, Lionel Feigenbaum, et al.. (2013). Normal viability of Kai1/Cd82 deficient mice. Molecular Carcinogenesis. 53(8). n/a–n/a. 14 indexed citations

Risinger, John I., Gadisetti V.R. Chandramouli, G. Larry Maxwell, et al.. (2007). Global Expression Analysis of Cancer/Testis Genes in Uterine Cancers Reveals a High Incidence of BORIS Expression. Clinical Cancer Research. 13(6). 1713–1719. 59 indexed citations

Vatolin, Sergei, Ziedulla Abdullaev, Svetlana Pack, et al.. (2005). Conditional Expression of the CTCF-Paralogous Transcriptional Factor BORIS in Normal Cells Results in Demethylation and Derepression of MAGE-A1 and Reactivation of Other Cancer-Testis Genes. Cancer Research. 65(17). 7751–7762. 167 indexed citations

Custer, Mary, John I. Risinger, Shelley Hoover, et al.. (2005). Characterization of an antibody that can detect the Kai1/CD82 murine metastasis suppressor. The Prostate. 66(6). 567–577. 15 indexed citations

Hong, Julie A., Kang Yang, Ziedulla Abdullaev, et al.. (2005). Reciprocal Binding of CTCF and BORIS to the NY-ESO-1 Promoter Coincides with Derepression of this Cancer-Testis Gene in Lung Cancer Cells. Cancer Research. 65(17). 7763–7774. 155 indexed citations

Clay, Timothy M., Mary Custer, Paul J. Spiess, & Michael I. Nishimura. (1999). Potential use of T cell receptor genes to modify hematopoietic stem cells for the gene therapy of cancer. Pathology & Oncology Research. 5(1). 3–15. 17 indexed citations

Clay, Timothy M., Mary Custer, Mark D. McKee, et al.. (1999). Changes in the Fine Specificity of gp100(209–217)-Reactive T Cells in Patients Following Vaccination with a Peptide Modified at an HLA-A2.1 Anchor Residue. The Journal of Immunology. 162(3). 1749–1755. 88 indexed citations

Clay, Timothy M., Mary Custer, Jessica Sachs, et al.. (1999). Efficient Transfer of a Tumor Antigen-Reactive TCR to Human Peripheral Blood Lymphocytes Confers Anti-Tumor Reactivity. The Journal of Immunology. 163(1). 507–513. 335 indexed citations

Nishimura, Michael I., Mary Custer, Susan Schwarz, et al.. (1998). T Cell-Receptor V Gene Use by CD4+ Melanoma-Reactive Clonal and Oligoclonal T-Cell Lines. Journal of Immunotherapy. 21(5). 352–362. 6 indexed citations

10.

Shilyansky, Joel, James Chih‐Hsin Yang, Mary Custer, et al.. (1997). Identification of a T-Cell Receptor from a Therapeutic Murine T-Cell Clone. Journal of Immunotherapy. 20(4). 247–225. 8 indexed citations

11.

Mulé, James J., Mary Custer, Bruce J. Averbook, et al.. (1996). RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of Tumorigenicity In Vivo: Role of Immune Cell Subpopulations. Human Gene Therapy. 7(13). 1545–1553. 115 indexed citations

12.

Shiloni, Eitan, Stephen E. Karp, Mary Custer, et al.. (1993). Retroviral transduction of interferon-? cDNA into a nonimmunogenic murinefibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor. Cancer Immunology Immunotherapy. 37(5). 286–292. 22 indexed citations

13.

Jicha, Douglas L., et al.. (1992). The Persistence of Human Peripheral Lymphocytes, Tumor Infiltrating Lymphocytes, and Colon Adenocarcinomas in Immunodeficient Mice. Journal of Immunotherapy. 11(1). 19–29. 15 indexed citations

14.

Hwu, Patrick, Susan Schwarz, Mary Custer, et al.. (1992). Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes. Journal of Immunological Methods. 151(1-2). 139–147. 7 indexed citations

15.

Mulé, James J., Mary Custer, William D. Travis, & Steven A. Rosenberg. (1992). Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice. The Journal of Immunology. 148(8). 2622–2629. 95 indexed citations

16.

Stötter, H, et al.. (1991). IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4. The Journal of Immunology. 146(1). 150–155. 65 indexed citations

17.

Custer, Mary & Michael T. Lotze. (1990). A biologic assay for IL-4 rapid fluorescence assay for IL-4 detection in supernatants and serum. Journal of Immunological Methods. 128(1). 109–117. 19 indexed citations

18.

Wiebke, Eric A., Mary Custer, Steven A. Rosenberg, & Michael T. Lotze. (1990). Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.. PubMed. 9(2). 113–26. 12 indexed citations

19.

Lotze, Michael T., et al.. (1990). Mechanisms of immunologic antitumor therapy: lessons from the laboratory and clinical applications. Human Immunology. 28(2). 198–207. 17 indexed citations

20.

Kawakami, Yutaka, Mary Custer, Steven A. Rosenberg, & Michael T. Lotze. (1989). IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.. The Journal of Immunology. 142(10). 3452–3461. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact